Restoril and Etoposide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Restoril (temazepam) and Etoposide (etoposide). Common drug interactions include muscle atrophy among females and abscess among males.

The phase IV clinical study analyzes what interactions people have when they take Restoril and Etoposide. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Restoril?

Restoril has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 13,522 Restoril users. Check the latest studies of Restoril.

What is Etoposide?

Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.

On Jul, 04, 2026

25 people who take Restoril and Etoposide together, and have interactions are studied.

Restoril and Etoposide drug interactions.

What are the common drug interactions of Restoril and Etoposide, by gender? *:

female:

Muscle atrophy (a decrease in the mass of the muscle)
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
Neutropenia (an abnormally low number of neutrophils)
Orthopnoea (shortness of breath (dyspnea) when lying down)
Pain
Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
Platelet count decreased
Pulmonary embolism (blockage of the main artery of the lung)
Respiratory failure (inadequate gas exchange by the respiratory system)
Restlessness (not able to rest)

male:

Abscess (pus)
Pneumonia
Ventricular fibrillation (abnormally irregular heart rhythm)
Abscess neck (neck abscesses)
Acute respiratory distress syndrome
Anaemia (lack of blood)
Ankle fracture
Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
Aortic thrombosis (formation of a blood clot inside aorta)
Asthenia (weakness)

What are the common drug interactions of Restoril and Etoposide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Febrile neutropenia (fever with reduced white blood cells)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)

50-59:

Muscle atrophy (a decrease in the mass of the muscle)
Nausea (feeling of having an urge to vomit)
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
Oedema peripheral (superficial swelling)
Orthopnoea (shortness of breath (dyspnea) when lying down)
Pain
Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
Pneumonia
Pyrexia (fever)
Restlessness (not able to rest)

60+:

Pneumonia
Chills (felling of cold)
Dizziness
Haemoglobin decreased
Hypotension (abnormally low blood pressure)
Plasma cell myeloma (cancer that begins in plasma cells)
Plasmacytoma (neoplasm of plasma cells (usually in bone marrow))
Platelet count decreased
Pulseless electrical activity
Respiratory failure (inadequate gas exchange by the respiratory system)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 9 people, 36.00%
Lung Cancer - Small Cell (lung cancer): 4 people, 16.00%
Constipation: 4 people, 16.00%
Nausea And Vomiting: 3 people, 12.00%
Nausea (feeling of having an urge to vomit): 3 people, 12.00%
Sleep Disorder: 2 people, 8.00%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 8.00%
High Blood Pressure: 2 people, 8.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.00%
Dyspnea (difficult or laboured breathing): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Restoril and Etoposide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously